BioSpace News Archive

Enrollment Complete for VALUE, the Prospective EU VasQ™ External Support Post-Market Study

Laminate Medical Technologies has announced the completion enrollment of the VALUE study for the VasQ™ External Support.

December 11, 2019
·
2 min read
Business

PDS Biotechnology Announces Resignation of James Loughlin from Board of Directors

PDS Biotechnology Corporation announced that James Loughlin has resigned from the Company’s board of directors to focus on his health and family, effective immediately.

December 11, 2019
·
4 min read
Job Trends

Matrix Medical Network to Co-Present AHIP Webinar

Matrix Medical Network, a leading provider of in-home and mobile health clinic assessments and care management will be co-presenting an upcoming America’s Health Insurance Plans webinar.

December 11, 2019
·
2 min read
Deals

Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock

Forty Seven, Inc., a clinical stage immuno-oncology company, announced that it has commenced an underwritten public offering of $140,000,000 of shares of its common stock.

December 11, 2019
·
1 min read
Drug Development

PDS Biotechnology Announces Principal Investigator and Independent Data Monitoring Committee for its Phase 2 Clinical Collaboration with Merck

Study evaluating PDS0101-KEYTRUDA® (pembrolizumab) Combination in First Line Treatment of Metastatic Head and Neck Cancer expected to be initiated in Q1 2020

December 11, 2019
·
6 min read
Policy

North Shore University Hospital earns Center of Excellence designation from Society for Obstetric Anesthesia and Perinatology, recognizing NAPA Obstetric Anesthesia team led by Greg Palleschi, MD, Director of Obstetric Anesthesiology

NAPA delivers anesthesia services at NSUH—one of only 39 hospitals worldwide and the only Long Island, NY, hospital to earn SOAP Center of Excellence distinction

December 11, 2019
·
3 min read
Business

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results

Fiscal 2019 Revenues Increase 114% over Fiscal 2018 to $54.4M

December 11, 2019
·
12 min read
Biotech Beach

Nihon Kohden Introduces First Subscription-Based Pricing for Patient Monitoring, Neurology Products

Subscription Models Allow Hospitals, Health Systems to Upgrade Critical Systems While Aligning Costs with Usage

December 11, 2019
·
3 min read
Drug Development

Biothera Pharmaceuticals Presents Updated Phase 2 Data for Chemo-refractory Triple Negative Breast Cancer Patients at San Antonio Breast Cancer Symposium

The study is evaluating Biothera’s Imprime PGG, a systemically delivered dectin receptor agonist that triggers anti-cancer immune responses, in combination with Merck’s anti-PD-1 therapy, KEYTRUDA®

December 11, 2019
·
3 min read
Drug Development

G1 Therapeutics Presents Updated Data from Phase 1b/2a Trial of Oral CDK4/6 Inhibitor Lerociclib at 2019 San Antonio Breast Cancer Symposium (SABCS)

Preliminary efficacy findings were consistent with other CDK4/6 inhibitors used in combination with fulvestrant.

December 11, 2019
·
6 min read